我国医保药品价格谈判机制与管理创新研究
发布时间：2018-12-29 19:00
【摘要】：医保药品价格谈判可显著提高患者对价格高昂但疗效确切的专利药、原研药的可获得性及可负担性,减轻患者的用药负担。我国的医保药品谈判正处于起步、探索阶段,最新的医保药品价格谈判结果即将形成,预示着我国的医保药品价格谈判将迈入新台阶。医保药品谈判机制应当具备可持续性及连续性,本文梳理我国药品谈判的进展及现状,并对国际典型的药品谈判机制特点及对我国的启示进行归纳分析,进而从设计目标、运行机制、配套机制等方面对我国的医保药品价格谈判机制管理体系进行设计,以期为完善我国的药品谈判机制提供借鉴,增强政策的可持续性。
[Abstract]:The price negotiation of medical insurance drugs can significantly improve the availability and affordability of patent drugs with high price but definite curative effect and lighten the burden of drug use. The negotiation of medical insurance drugs in our country is in the starting stage, exploring stage, and the latest negotiation result of medical insurance drug price is coming into being, which indicates that the negotiation of medical insurance drug price in our country will enter a new level. The mechanism of medical drug negotiation should be sustainable and continuous. This paper reviews the progress and current situation of drug negotiation in China, and summarizes and analyzes the characteristics of the international typical drug negotiation mechanism and its inspiration to China, and then analyzes the design objectives from the point of view of the international drug negotiation mechanism. This paper designs the management system of medical insurance drug price negotiation mechanism in China from the aspects of operation mechanism and supporting mechanism in order to provide reference for perfecting the drug negotiation mechanism in our country and to enhance the policy sustainability.
【作者单位】： 中国药科大学国际医药商学院;
【分类号】：F842.684;R197.1
本文编号：2395257
[Abstract]:The price negotiation of medical insurance drugs can significantly improve the availability and affordability of patent drugs with high price but definite curative effect and lighten the burden of drug use. The negotiation of medical insurance drugs in our country is in the starting stage, exploring stage, and the latest negotiation result of medical insurance drug price is coming into being, which indicates that the negotiation of medical insurance drug price in our country will enter a new level. The mechanism of medical drug negotiation should be sustainable and continuous. This paper reviews the progress and current situation of drug negotiation in China, and summarizes and analyzes the characteristics of the international typical drug negotiation mechanism and its inspiration to China, and then analyzes the design objectives from the point of view of the international drug negotiation mechanism. This paper designs the management system of medical insurance drug price negotiation mechanism in China from the aspects of operation mechanism and supporting mechanism in order to provide reference for perfecting the drug negotiation mechanism in our country and to enhance the policy sustainability.
【作者单位】： 中国药科大学国际医药商学院;
【分类号】：F842.684;R197.1
【相似文献】
相关期刊论文 前7条
1 邹宪;;探索机制创新促推“三医”改革 我社召开“医保与医药谈判机制座谈会”[J];中国医疗保险;2010年08期
2 于志奎;张索来;;谈判机制在降低医疗费用方面的作用探讨[J];中国卫生资源;2012年02期
3 杨宜勇;杨亚哲;;建立谈判机制 控制医药费用[J];中国医疗保险;2009年12期
4 海韵;;以谈判机制为抓手助推“三医”联动[J];中国医疗保险;2010年08期
5 晓前;;亟待给力的谈判机制[J];中国医疗保险;2011年09期
6 王秀英;;新医改实践中建立和运用医保管理谈判机制的思考[J];江苏卫生事业管理;2012年02期
7 ;王深明:建立谈判机制亟待解决三个问题[J];中国医疗保险;2010年08期
相关重要报纸文章 前4条
1 本报记者 武唯;药价谈判机制如何发力？[N];中国劳动保障报;2009年
2 史传芝 林慧 克勤;新疆将特慢病门诊用药引入谈判新机制[N];中国劳动保障报;2012年
3 闫俊;理论支撑 现实推动[N];中国劳动保障报;2011年
4 本报记者 杨俊坚 实习生 董红燕;谈判机制成解决药价虚高抓手[N];医药经济报;2013年
，本文编号：2395257
本文链接：https://www.wllwen.com/jingjilunwen/bxjjlw/2395257.html
